SOFOSBUVIR 400 mg (Sovihep) is a prescription antiviral medicine used in combination with other antiviral medicines to treat chronic hepatitis C virus (HCV) infection. It belongs to a class of medicines called NS5B polymerase inhibitors and works by preventing the virus from multiplying. When used as part of the recommended treatment regimen, sofosbuvir can help patients achieve a sustained virologic response (SVR), which means the hepatitis C virus is no longer detected after treatment.
| Generic name | SOFOSBUVIR |
| Strength | 400 mg |
| Manufacturer | ZYDUS |
| Package size | 28 Tablets |
| Used for | Chronic hepatitis C virus (HCV) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Daclatasvir 60 mg + Sofosbuvir 400 mg (Sovihep D) is a combination antiviral medicine used to treat chronic hepatitis C virus (HCV) infection. It works by preventing the virus from multiplying and helps clear HCV from the body. When taken exactly as prescribed, this combination may improve liver health, reduce the risk of further liver damage, and provide high cure rates in suitable patients.
| Generic name | Daclatasvir/Sofosbuvir |
| Strength | 60 mg + 400 mg |
| Manufacturer | ZYDUS |
| Package size | 28 Tablets |
| Used for | Chronic hepatitis C virus (HCV) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
RIBAVIRIN 200 mg (Ribasure) is a prescription antiviral medicine used in combination with other antiviral medicines to treat chronic hepatitis C and certain other viral infections in specific clinical settings. It works by interfering with viral replication and helping reduce the amount of virus in the body. Ribavirin should always be taken exactly as prescribed and is generally used as part of combination therapy rather than on its own.
| Generic name | RIBAVIRIN |
| Strength | 200 mg |
| Manufacturer | APRAZER |
| Package size | 140 Capsules |
| Used for | Chronic hepatitis C, respiratory syncytial virus (RSV), and severe viral fevers like Lassa fever |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Daclatasvir 60 mg (Natdac) is an antiviral medicine used to treat chronic hepatitis C virus (HCV) infection. It is prescribed in combination with other antiviral medicines, such as sofosbuvir, to help eliminate the virus from the body. Daclatasvir may help reduce further liver damage and lower the risk of serious complications associated with chronic hepatitis C when taken as prescribed.
| Generic name | Daclatasvir |
| Strength | 60 mg |
| Manufacturer | Natco Pharma |
| Package size | 28 Tablets |
| Used for | Chronic hepatitis C virus (HCV) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Ledipasvir 90 mg + Sofosbuvir 400 mg (Myhep LVIR) is a combination antiviral medicine used to treat chronic hepatitis C virus (HCV) infection. It works by targeting different stages of the hepatitis C virus life cycle, helping stop viral replication and clear the infection. This treatment can provide high cure rates for suitable patients when taken exactly as prescribed.
| Generic name | Ledipasvir/Sofosbuvir |
| Strength | 90 mg + 400 mg |
| Manufacturer | MYLAN |
| Package size | 28 Tablets |
| Used for | Chronic hepatitis C virus (HCV) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
SOFOSBUVIR 400 mg + VELPATASVIR 100 mg is a prescription antiviral medication used to treat chronic hepatitis C virus (HCV) infection in adults. This fixed-dose combination contains sofosbuvir, an NS5B polymerase inhibitor, and velpatasvir, an NS5A inhibitor, providing effective treatment against all major hepatitis C genotypes. When taken as prescribed, it can help achieve a sustained virologic response (SVR), which is considered a cure for many patients.
| Generic name | SOFOSBUVIR/VELPATASVIR |
| Strength | 400 mg + 100 mg |
| Manufacturer | Cipla |
| Package size | 28 Tablets |
| Used for | Chronic hepatitis C virus (HCV) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
THYMOSIN ALPHA 1.6 mg (Guficin) Injection is a prescription immunomodulatory medication used to support and strengthen the body’s immune response. It is commonly used as an adjunct treatment in conditions such as chronic hepatitis B, certain infections, and selected cancers under specialist supervision. The injection helps improve immune cell function, enabling the body to better fight infections and support overall immune health.
| Generic name | THYMOSIN ALPHA |
| Strength | 1.6 mg |
| Manufacturer | Gufic Bioscience Limited |
| Package size | 1 vial |
| Used for | Chronic hepatitis B and C |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
